Time to blood culture positivity as a predictor of drug resistance in Acinetobacter baumannii complex bacteremia

Journal of Infection

Volumn 63, Issue 1, 2011, Pages 96-98

  Lai, Chih Cheng ^a   Wang, Cheng Yi ^b   Liu, Wei Lun ^a   Cheng, Aris ^c   Lee, Yi Chieh ^c   Huang, Yu Tsung ^c   Hsueh, Po Ren ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; DIAGNOSTIC TEST; HUMAN; LETTER; MAJOR CLINICAL STUDY; NONHUMAN; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; TIME TO BLOOD CULTURE POSITIVITY;

BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BLOOD; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 79959614567     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.05.009     Document Type: Letter

References (14)

1. Lai C.C., Wang C.Y., Liu W.L., Huang Y.T., Liao C.H., Hsueh P.R. Time to positivity in blood cultures of staphylococci: clinical significance in bacteremia. J Infect 2011, 62:249-251.
2. Lai C.C., Wang C.Y., Liu W.L., Hou C.C., Huang Y.T., Hsueh P.R. Time to blood culture positivity as a predictor of methicillin resistance in Staphylococcus aureus bacteremia. J Infect 2011, 62:190-191.
3. Allen D.M., Hartman B.J. Acinetobacter species. Mandell, Douglas and Bennett's principles and practice of infectious diseases 2010, 2881-2925. Churchill Livingstone, Edinburgh. 7th ed. G.L. Mandell, G.E. Bennett, R. Dolin (Eds.).
4. Hirai Y. Survival of bacteria under dry conditions: from a viewpoint of nosocomial infection. J Hosp Infect 1991, 19:191-200.
5. Larson E.L. Persistent carriage of gram-negative bacteria on hands. Am J Infect Control 1981, 9:112-119.
6. Rosenthal S., Tager I.B. Prevalence of gram-negative rods in the normal pharyngeal flora. Ann Intern Med 1975, 83:355-357.
7. Wendt C., Dietze B., Dietz E., Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 1997, 35:1394-1397.
8. Seifert H., Strate A., Pulverer G. Nosocomial bacteraemia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995, 74:340-349.
9. Maragakis L.L., Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008, 46:1254-1263.
10. Erbay A., Idil A., Gözel M.G., Mumcuoĝlu I., Balaban N. Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections. Int J Antimicrob Agents 2009, 34:575-579.
11. Kwon K.T., Oh W.S., Song J.H., Chang H.H., Jung S.I., Kim S.W., et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 2007, 59:525-530.
12. Performance standards for antimicrobial disk susceptibility tests; approved standard 2006, Clinical Laboratory Standards Institute, CLSI, Wayne, PA. 9th ed.
13. Ko W.C., Lee N.Y., Su S.C., Dijkshoom L., Vaneechoutte M., Wang L.R., et al. Oligunucleotide-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates. J Clin Microbiol 2008, 46:2052-2059.
14. Lin Y.C., Sheng W.H., Chang S.C., Wang J.Y., Chen Y.C., Wu R.J., et al. Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities. J Clin Microbiol 2008, 46:612-617.